Intratio
Loading...
Skip to main content
Model output · Signal date Oct. 14, 2026

Daily SignalsNeutral

2487 companies scored · 2026-10-14 run in progress: 2171 of ~5379 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D

Signal date 2026-10-14 Cut-offs from the 2026-10-13 run
Companies scored 2487 IC ≥ 0 · market cap ≥ $100M
Median forecast +3.08% Total · 90D
Long–short spread +4.99% Strong Buy minus Strong Sell, mean
Median IC 0.29 Spearman · 90D
Rating changes ▲ 47 ▼ 42 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · Neutral

65 companies

Sorted by 90D forecast ↓

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
1 AGENAGENUS INC Life Sciences 0.08 $313M Neutral +1.34% +3.37% ·
2 TRLVTrulieve Cannabis Corp. Life Sciences 0.06 $1.9B Neutral +1.18% +3.34% ·
3 ELVNEnliven Therapeutics, Inc. Life Sciences 0.40 $2.9B Neutral +1.30% +3.32% ·
4 INOINOVIO PHARMACEUTICALS, INC. Life Sciences 0.23 $103M Neutral +1.14% +3.28% ·
5 ROIVRoivant Sciences Ltd. Life Sciences 0.42 $24.1B Neutral +1.19% +3.22% ·
6 HALOHALOZYME THERAPEUTICS, INC. Life Sciences 0.49 $12.4B Neutral +1.01% +3.21% ·
7 PRGOPERRIGO Co plc Life Sciences 0.56 $2.1B Neutral +1.22% +3.20% ·
8 NAGENiagen Bioscience, Inc. Life Sciences 0.67 $204M Neutral +1.26% +3.19% ·
9 ADXNAddex Therapeutics Ltd. Life Sciences 0.02 $449M Neutral +1.21% +3.17% ·
10 ABUSArbutus Biopharma Corp Life Sciences 0.03 $813M Neutral +1.16% +3.16% ·
11 KRYSKrystal Biotech, Inc. Life Sciences 0.02 $9.5B Neutral +0.75% +3.14% ·
12 PFEPFIZER INC Life Sciences 0.34 $161.7B Neutral +0.72% +3.12% ·
13 HRMYHarmony Biosciences Holdings, Inc. Life Sciences 0.31 $2.2B Neutral +0.99% +3.11% ·
14 PLYXPolaryx Therapeutics, Inc. Life Sciences 0.64 $100M Neutral +1.02% +3.10% ·
15 NBPNovaBridge Biosciences Life Sciences 0.59 $342M Neutral +1.04% +3.08% ·
16 SMMTSummit Therapeutics Inc. Life Sciences 0.33 $12.4B Neutral +1.08% +3.08% ·
17 VCELVericel Corp Life Sciences 0.27 $2.1B Neutral +0.76% +3.07% ·
18 ANABANAPTYSBIO, INC Life Sciences 0.56 $1.3B Neutral +0.85% +3.05% ·
19 ETONEton Pharmaceuticals, Inc. Life Sciences 0.13 $1.5B Neutral +1.13% +3.05% ·
20 VNDAVanda Pharmaceuticals Inc. Life Sciences 0.38 $260M Neutral +1.08% +3.05% ·
21 CGENCOMPUGEN LTD Life Sciences 0.42 $196M Neutral +0.99% +3.04% ·
22 IMCRImmunocore Holdings plc Life Sciences 0.12 $1.4B Neutral +1.01% +3.03% ·
23 ARVNARVINAS, INC. Life Sciences 0.28 $447M Neutral +1.37% +3.02% ·
24 IMRXImmuneering Corp Life Sciences 0.12 $230M Neutral +1.32% +3.01% ·
25 RPRXRoyalty Pharma plc Life Sciences 0.60 $32.5B Neutral +0.85% +3.00% ·
26 NRXPNRX Pharmaceuticals, Inc. Life Sciences 0.01 $117M Neutral +1.19% +2.98% ·
27 AMRXAmneal Pharmaceuticals, Inc. Life Sciences 0.02 $6.2B Neutral +0.99% +2.97% ·
28 DFTXDefinium Therapeutics, Inc. Life Sciences 0.29 $4.6B Neutral +1.30% +2.97% ·
29 INDVIndivior Pharmaceuticals, Inc. Life Sciences 0.35 $4.2B Neutral +0.73% +2.97% ·
30 MGTXMeiraGTx Holdings plc Life Sciences 0.10 $955M Neutral +1.31% +2.97% ·
31 AUPHAurinia Pharmaceuticals Inc. Life Sciences 0.16 $2.2B Neutral +0.70% +2.94% ·
32 ALKSAlkermes plc. Life Sciences 0.32 $6.7B Neutral +1.09% +2.92% ·
33 MLYSMineralys Therapeutics, Inc. Life Sciences 0.28 $1.9B Neutral +1.42% +2.91% ·
34 GALTGALECTIN THERAPEUTICS INC Life Sciences 0.10 $390M Neutral +1.04% +2.83% ·
35 OLMAOlema Pharmaceuticals, Inc. Life Sciences 0.53 $614M Neutral +1.68% +2.82% ·
36 CYTKCYTOKINETICS INC Life Sciences 0.20 $8.6B Neutral +0.93% +2.80% ·
37 LENZLENZ Therapeutics, Inc. Life Sciences 0.58 $107M Neutral +0.98% +2.69% ·
38 NIKANIKA PHARMACEUTICALS, INC Life Sciences 0.20 $431M Neutral -0.77% +2.69% ·
39 PRTAPROTHENA CORP PUBLIC LTD CO Life Sciences 0.31 $429M Neutral +1.19% +2.68% ·
40 TEVATEVA PHARMACEUTICAL INDUSTRIES LTD Life Sciences 0.01 $48.1B Neutral +0.59% +2.68% ·
41 SIGASIGA TECHNOLOGIES INC Life Sciences 0.46 $221M Neutral +1.04% +2.67% ·
42 BNTXBioNTech SE Life Sciences 0.00 $22.5B Neutral +0.83% +2.66% ·
43 LLYELI LILLY & Co Life Sciences 0.29 $1.1T Neutral +0.55% +2.65% ·
44 NRIXNurix Therapeutics, Inc. Life Sciences 0.23 $2.3B Neutral +0.96% +2.65% ·
45 PTCTPTC THERAPEUTICS, INC. Life Sciences 0.25 $5.0B Neutral +1.07% +2.62% ·
46 GILDGILEAD SCIENCES, INC. Life Sciences 0.26 $183.4B Neutral +0.96% +2.61% ·
47 XTLBXTL BIOPHARMACEUTICALS LTD Life Sciences 0.15 $1.8B Neutral +1.14% +2.61% ·
48 IONSIONIS PHARMACEUTICALS INC Life Sciences 0.53 $7.0B Neutral +1.37% +2.57% ·
49 OCULOCULAR THERAPEUTIX, INC Life Sciences 0.15 $1.6B Neutral +1.81% +2.57% ·
50 WVEWave Life Sciences, Inc. Life Sciences 0.49 $619M Neutral +1.19% +2.56% ·
1–50 of 65 Previous Next
Since the previous run

Rating changes

▲ 47▼ 42
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.